These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8104473)

  • 21. Interaction of human immunodeficiency virus glycoprotein 160 with CD4 in Jurkat cells increases p56lck autophosphorylation and kinase activity.
    Soula M; Fagard R; Fischer S
    Int Immunol; 1992 Feb; 4(2):295-9. PubMed ID: 1535787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An octapeptide analogue of HIV gp120 modulates protein tyrosine kinase activity in activated peripheral blood T lymphocytes.
    Phipps DJ; Reed-Doob P; MacFadden DK; Piovesan JP; Mills GB; Branch DR
    Clin Exp Immunol; 1995 Jun; 100(3):412-8. PubMed ID: 7539724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production of transmembrane and secreted forms of tumor necrosis factor (TNF)-alpha by HIV-1-specific CD4+ cytolytic T lymphocyte clones. Evidence for a TNF-alpha-independent cytolytic mechanism.
    Liu AY; Miskovsky EP; Stanhope PE; Siliciano RF
    J Immunol; 1992 Jun; 148(12):3789-98. PubMed ID: 1351088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retroviral vector-mediated expression in primary human T cells of an endoplasmic reticulum-retained CD4 chimera inhibits human immunodeficiency virus type-1 replication.
    San José E; Muñoz-Fernández MA; Alarcón B
    Hum Gene Ther; 1998 Jun; 9(9):1345-57. PubMed ID: 9650619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stable expression of the human immunodeficiency virus type 1 envelope glycoprotein in transfected L cells.
    Bird C; Gleeson PA; Ramsay A; Li P; McCluskey J
    AIDS Res Hum Retroviruses; 1992 Dec; 8(12):1999-2009. PubMed ID: 1493050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human immunodeficiency virus type 1-associated CD4 downmodulation.
    Geleziunas R; Bour S; Wainberg MA
    Adv Virus Res; 1994; 44():203-66. PubMed ID: 7817874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro binding and internalization of HIV envelope glycoproteins by human epidermal Langerhans cells does not require the CD4-gp120-binding site.
    Schmitt D; Dezutter-Dambuyant C; Hanau D; Kolbe HV; Kieny MP; Cazenave JP; Thivolet J
    Res Virol; 1990; 141(2):209-15. PubMed ID: 1693220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-1 down-regulates CD4 costimulation of TCR/CD3-directed tyrosine phosphorylation through CD4/p56lck dissociation.
    Kanner SB; Haffar OK
    J Immunol; 1995 Mar; 154(6):2996-3005. PubMed ID: 7876562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV envelope glycoprotein-induced cell killing by apoptosis is enhanced with increased expression of CD26 in CD4+ T cells.
    Jacotot E; Callebaut C; Blanco J; Rivière Y; Krust B; Hovanessian AG
    Virology; 1996 Sep; 223(2):318-30. PubMed ID: 8806567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutational analysis of HIV-1 gp160-mediated receptor interference: intracellular complex formation.
    Martin RA; Nayak DP
    Virology; 1996 Jun; 220(2):461-72. PubMed ID: 8661396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extensive C-terminal deletion in human immunodeficiency virus type 1 Env glycoprotein arising after long-term culture of chronically infected cells.
    Zaides V; Yagello M; Veselovskaya T; Schmitt D; Rykova L; Fenouillet E; Gluckman JC
    J Gen Virol; 1994 Nov; 75 ( Pt 11)():2963-75. PubMed ID: 7964606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An HIV-1 envelope protein vaccine elicits a functionally complex human CD4+ T cell response that includes cytolytic T lymphocytes.
    Stanhope PE; Liu AY; Pavlat W; Pitha PM; Clements ML; Siliciano RF
    J Immunol; 1993 May; 150(10):4672-86. PubMed ID: 8097759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection.
    Bour S; Geleziunas R; Wainberg MA
    Microbiol Rev; 1995 Mar; 59(1):63-93. PubMed ID: 7708013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Membrane-interactive phospholipids inhibit HIV type 1-induced cell fusion and surface gp160/gp120 binding to monoclonal antibody.
    Krugner-Higby L; Goff D; Edwards T; Iyer N; Neufeld J; Kute T; Morris-Natschke S; Ishaq K; Piantadosi C; Kucera LS
    AIDS Res Hum Retroviruses; 1995 Jun; 11(6):705-12. PubMed ID: 7576930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Membrane anchorage of gp160 is necessary and sufficient to prevent CD4 transport to the cell surface.
    Martin RA; Nayak DP
    Virology; 1996 Jun; 220(2):473-9. PubMed ID: 8661397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diminution of CD4 surface protein but not CD4 messenger RNA levels in monocytic cells infected by HIV-1.
    Geleziunas R; Bour S; Boulerice F; Hiscott J; Wainberg MA
    AIDS; 1991 Jan; 5(1):29-33. PubMed ID: 2059359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium requirement and inhibitor spectrum for intracellular HIV type 1 gp160 processing in cultured HeLa cells and CD4+ lymphocytes: similarity to those of viral envelope glycoprotein maturase.
    Kamoshita K; Shiota M; Sasaki M; Koga Y; Okumura Y; Kido H
    J Biochem; 1995 Jun; 117(6):1244-53. PubMed ID: 7490267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1 associated down-modulation of CD4 gene expression is differentially restricted in lymphocytic and monocytic cell lines.
    Geleziunas R; Bour S; Wainberg MA
    J Leukoc Biol; 1994 May; 55(5):589-95. PubMed ID: 8182337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction by human immunodeficiency viruses types 1 and 2 of degradation of CD4 but not of a CD4 mutant unable to bind viral envelope glycoproteins.
    Cucchiarini M; Cagnon L; Giordanengo V; Doglio A; Lefebvre JC
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(5):427-36. PubMed ID: 7697438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines.
    Fenouillet E; Miquelis R; Drillien R
    Virology; 1996 Apr; 218(1):224-31. PubMed ID: 8615025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.